(secondQuint)MyoSure Hysteroscopic Tissue Removal System Registry Study.

 Between 500 and 600 subjects will be enrolled in a prospective, multi-center registry study.

 Approximately 100 of these cases will be completed in an office setting, with the remaining 400-500 cases completed in a hospital outpatient or ambulatory surgery center.

 Subjects will undergo a hysteroscopic tissue removal procedure to remove intrauterine polyps and submucosal fibroids.

.

 MyoSure Hysteroscopic Tissue Removal System Registry Study@highlight

The objective of this study is to demonstrate the safety and effectiveness of community gynecologist initiated treatment of intra-uterine polyps and submucosal fibroids with the MyoSure Hysteroscopic Tissue Removal System in a significantly sized patient population.

